2023 Q3 Form 10-Q Financial Statement

#000143774923024195 Filed on August 21, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $166.6K $4.240K
YoY Change 3830.19% -98.44%
Cash & Equivalents $166.6K $4.236K
Short-Term Investments
Other Short-Term Assets $1.102M $670.00
YoY Change 164344.78% -81.84%
Inventory $116.2K
Prepaid Expenses $670.00
Receivables $115.8K $5.008K
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.384M $126.1K
YoY Change 997.6% -68.73%
LONG-TERM ASSETS
Property, Plant & Equipment $138.3K $6.913K
YoY Change 1900.84% -96.26%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $10.14K
YoY Change 0.0%
Total Long-Term Assets $417.2K $145.8K
YoY Change 186.15% -25.14%
TOTAL ASSETS
Total Short-Term Assets $1.384M $126.1K
Total Long-Term Assets $417.2K $145.8K
Total Assets $1.801M $271.9K
YoY Change 562.48% -54.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $419.6K $396.3K
YoY Change 5.86% 6.02%
Accrued Expenses $1.686M $956.3K
YoY Change 76.32% 11.81%
Deferred Revenue
YoY Change
Short-Term Debt $349.9K $104.5K
YoY Change 234.83%
Long-Term Debt Due $114.9K
YoY Change 2.58%
Total Short-Term Liabilities $3.591M $1.572M
YoY Change 128.46% 17.22%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $147.1K
YoY Change -100.0% -34.64%
Other Long-Term Liabilities $364.1K $76.04K
YoY Change 378.8% -40.94%
Total Long-Term Liabilities $364.1K $223.2K
YoY Change 63.15% -36.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.591M $1.572M
Total Long-Term Liabilities $364.1K $223.2K
Total Liabilities $3.955M $1.795M
YoY Change 120.34% 5.91%
SHAREHOLDERS EQUITY
Retained Earnings -$17.18M -$16.92M
YoY Change 1.52% 3.56%
Common Stock $78.27K $5.571K
YoY Change 1304.92%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.154M -$1.523M
YoY Change
Total Liabilities & Shareholders Equity $1.801M $271.9K
YoY Change 562.48% -54.53%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 dei Entity Registrant Name
EntityRegistrantName
WOLF ENERGY SERVICES INC.
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001043894
CY2023Q2 dei Amendment Flag
AmendmentFlag
false
CY2023Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2023Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
78268332
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
78268332
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
78268332
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
78268332
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
78268332
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
78268332
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
4 pure
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
40000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.025
CY2023Q2 dei Document Type
DocumentType
10-Q
CY2023Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q2 dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
CY2023Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q2 dei Entity File Number
EntityFileNumber
000-30454
CY2023Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
CY2023Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-0266517
CY2023Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
408 State Highway 135 N
CY2023Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Kilgore
CY2023Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75662
CY2023Q2 dei City Area Code
CityAreaCode
903
CY2023Q2 dei Local Phone Number
LocalPhoneNumber
392-0948
CY2023Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q2 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
78268332
CY2023Q2 us-gaap Cash
Cash
166644 usd
CY2023Q1 us-gaap Cash
Cash
574233 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
115795 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
146836 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1071113 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
516370 usd
CY2023Q2 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
30672 usd
CY2023Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
60362 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
1384224 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
1297801 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
138318 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
686327 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
278919 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
297744 usd
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
417237 usd
CY2023Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
984071 usd
CY2023Q2 us-gaap Assets
Assets
1801461 usd
CY2023Q1 us-gaap Assets
Assets
2281872 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
419583 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
229267 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1686147 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1055862 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
845565 usd
CY2023Q1 us-gaap Notes Payable Current
NotesPayableCurrent
845565 usd
CY2023Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
349895 usd
CY2023Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
511777 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
67543 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
71758 usd
CY2023Q2 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
222626 usd
CY2023Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
238028 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3591359 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2952257 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
214076 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
227786 usd
CY2023Q2 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
150000 usd
CY2023Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
150000 usd
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
364076 usd
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
377786 usd
CY2023Q2 us-gaap Liabilities
Liabilities
3955435 usd
CY2023Q1 us-gaap Liabilities
Liabilities
3330043 usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
78268 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
78268 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
14944041 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
14906541 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17176283 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16032980 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-2153974 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1048171 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1801461 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2281872 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2343558 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5418655 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1538813 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4512249 usd
CY2023Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
315347 usd
CY2022Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
263321 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1166140 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1209725 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
29056 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
112829 usd
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
3049356 usd
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
6098124 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-705798 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-679469 usd
CY2023Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-298953 usd
CY2022Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-950024 usd
CY2023Q2 us-gaap Investment Income Net
InvestmentIncomeNet
-107028 usd
CY2022Q2 us-gaap Investment Income Net
InvestmentIncomeNet
-7278 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-405981 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-957302 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1111779 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1636771 usd
CY2023Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
-28287 usd
CY2022Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
0 usd
CY2023Q2 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
0 usd
CY2022Q2 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
0 usd
CY2023Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-28287 usd
CY2022Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
0 usd
CY2023Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-1140066 usd
CY2022Q2 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-1636771 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3237 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1143303 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1636771 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.01
CY2022Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.03
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2022Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
78268332
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51987832
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
7642244 usd
CY2022Q2 evtn Adjustments To Additional Paid In Capital Advances From Parent
AdjustmentsToAdditionalPaidInCapitalAdvancesFromParent
392484 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1636771 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
6397957 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1048171 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
37500 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1143303 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-2153974 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1143303 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1636771 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
29056 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
112829 usd
CY2023Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-298953 usd
CY2022Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-950024 usd
CY2023Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
37500 usd
CY2022Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
0 usd
CY2023Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3960 usd
CY2022Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-31041 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-58405 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
554743 usd
CY2022Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1491522 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
23665 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
15234 usd
CY2023Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
0 usd
CY2022Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
36591 usd
CY2023Q2 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
-0 usd
CY2022Q2 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
6113 usd
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
22765 usd
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
16948 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
820601 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1403852 usd
CY2023Q2 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
667268 usd
CY2022Q2 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
1454836 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-476035 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-181935 usd
CY2023Q2 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
14288 usd
CY2022Q2 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
0 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-461747 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-181935 usd
CY2023Q2 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
220000 usd
CY2022Q2 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
580000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
220000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
580000 usd
CY2023Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
-0 usd
CY2022Q2 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
29775 usd
CY2023Q2 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
-0 usd
CY2022Q2 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
436407 usd
CY2023Q2 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
165842 usd
CY2022Q2 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
-0 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-165842 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-466182 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-407589 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-68117 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
574233 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
99452 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
166644 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
31335 usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
12189 usd
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2022Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2022Q3 evtn Number Of Subsidiaries
NumberOfSubsidiaries
1 pure
CY2023Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
4 pure
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2023Q2 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Use of Estimates</i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of revenues and expenses during the reporting period. These estimates include, but are <em style="font: inherit;">not</em> limited to, management’s estimate of provisions required for uncollectible accounts receivable, impaired value of equipment and intangible assets, liabilities to accrue, cost incurred in the satisfaction of performance obligations, permanent and temporary differences related to income taxes, to present these consolidated financial statements on a standalone basis and determination of the fair value of stock awards.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Actual results could differ from those estimates.</p>
CY2023Q2 evtn Accounts Receivable Percentage Of Amount Invoiced Recognized As Revenue
AccountsReceivablePercentageOfAmountInvoicedRecognizedAsRevenue
1 pure
CY2023Q2 evtn Accounts Receivable Percentage Of Amount Invoiced Finance Charge Expense
AccountsReceivablePercentageOfAmountInvoicedFinanceChargeExpense
0.02 pure
CY2023Q2 evtn Accounts Receivable Percentage Of Amount Invoiced Net Proceeds Received
AccountsReceivablePercentageOfAmountInvoicedNetProceedsReceived
0.98 pure
CY2023Q2 evtn Accounts Receivable Percentage Of Amount Invoiced Net Proceeds Received
AccountsReceivablePercentageOfAmountInvoicedNetProceedsReceived
0.925 pure
CY2023Q2 evtn Accounts Receivable Percentage Of Amount Invoiced Recognized As Revenue
AccountsReceivablePercentageOfAmountInvoicedRecognizedAsRevenue
1 pure
CY2023Q2 evtn Accounts Receivable Percentage Of Fee Charged By Agent
AccountsReceivablePercentageOfFeeChargedByAgent
0.075 pure
CY2023Q2 evtn Accounts Receivable Percentage Of Amount Invoiced Net Proceeds Received
AccountsReceivablePercentageOfAmountInvoicedNetProceedsReceived
0.925 pure
CY2023Q2 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Reclassifications</i></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company has reclassified certain amounts in the <em style="font: inherit;"> June 30, 2022 </em>condensed consolidated financial statements to be consistent with the <em style="font: inherit;"> June 30, 2023 </em>presentation. These changes had <em style="font: inherit;">no</em> impact on the Company’s financial position or result of operations for the periods presented.</p>
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1296571 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-1111779 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-1636771 usd
CY2023Q2 evtn Working Capital Deficit
WorkingCapitalDeficit
2207135 usd
CY2023Q1 evtn Working Capital Deficit
WorkingCapitalDeficit
1654456 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17176283 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
166644 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2343558 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5418655 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1347973 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
138318 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
686327 usd
CY2023Q2 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 usd
CY2022Q2 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
1530024 usd
CY2022Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
580000 usd
CY2022Q4 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-21227 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-333976 usd
CY2023Q1 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
28723 usd
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
7500 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-21223 usd
CY2023Q2 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
118266 usd
CY2023Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
75000 usd
CY2023Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-43266 usd
CY2023Q2 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
400688 usd
CY2023Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
145000 usd
CY2023Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-255688 usd
CY2023Q2 us-gaap Depreciation
Depreciation
29056 usd
CY2022Q2 us-gaap Depreciation
Depreciation
48586 usd
CY2023Q2 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
1088376 usd
CY2023Q1 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
382197 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
547374 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
615200 usd
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
42277 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
29979 usd
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4883 usd
CY2023Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
15540 usd
CY2023Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
3237 usd
CY2023Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
12947 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1686147 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1055862 usd
CY2023Q2 us-gaap Notes Payable
NotesPayable
1195460 usd
CY2023Q1 us-gaap Notes Payable
NotesPayable
1357342 usd
CY2023Q2 evtn Shortterm Debt And Notes Payable Current
ShorttermDebtAndNotesPayableCurrent
1195460 usd
CY2023Q1 evtn Shortterm Debt And Notes Payable Current
ShorttermDebtAndNotesPayableCurrent
1357342 usd
CY2023Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
0 usd
CY2023Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
0 usd
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
78268332
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
78268332
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
40000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.025
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2300 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
278919 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
281619 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
80307 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
70500 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
72000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
72000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive
35102 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
48290 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
281619 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
67543 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
214076 usd
CY2023Q2 evtn Rightofuse Asset Amortization Expense Next Rolling12 Months
RightofuseAssetAmortizationExpenseNextRolling12Months
71143 usd
CY2023Q2 evtn Rightofuse Asset Amortization Expense Rolling Year Two
RightofuseAssetAmortizationExpenseRollingYearTwo
60257 usd
CY2023Q2 evtn Rightofuse Asset Amortization Expense Rolling Year Three
RightofuseAssetAmortizationExpenseRollingYearThree
63450 usd
CY2023Q2 evtn Operating Lease Rightofuse Asset Amortization Expense Rolling Year Four
OperatingLeaseRightofuseAssetAmortizationExpenseRollingYearFour
66818 usd
CY2023Q2 evtn Operating Lease Rightofuse Asset Amortization Expense Rolling Year Five
OperatingLeaseRightofuseAssetAmortizationExpenseRollingYearFive
17251 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
278919 usd
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
22765 usd
CY2023 us-gaap Operating Lease Expense
OperatingLeaseExpense
16552 usd
CY2023Q2 evtn Finance Lease Rightofuse Asset Depreciation
FinanceLeaseRightofuseAssetDepreciation
0 usd
CY2023 evtn Finance Lease Rightofuse Asset Depreciation
FinanceLeaseRightofuseAssetDepreciation
56576 usd
CY2023Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
0 usd
CY2023 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1934 usd
CY2023Q2 us-gaap Lease Cost
LeaseCost
22765 usd
CY2023 us-gaap Lease Cost
LeaseCost
75062 usd

Files In Submission

Name View Source Status
0001437749-23-024195-index-headers.html Edgar Link pending
0001437749-23-024195-index.html Edgar Link pending
0001437749-23-024195.txt Edgar Link pending
0001437749-23-024195-xbrl.zip Edgar Link pending
evtn-20230630.xsd Edgar Link pending
evtn20230630_10q.htm Edgar Link pending
ex_556926.htm Edgar Link pending
ex_556927.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
evtn20230630_10q_htm.xml Edgar Link completed
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
evtn-20230630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
evtn-20230630_pre.xml Edgar Link unprocessable
evtn-20230630_cal.xml Edgar Link unprocessable
evtn-20230630_def.xml Edgar Link unprocessable